Biotype hypochlorous acid/HOCL/Anolyte has significant clinical application value in the treatment of flesh-eating bacteria infections.
Flesh-eating bacteria infection is a necrotizing soft tissue infection caused by Streptococcus, Staphylococcus aureus and other bacteria. It is characterized by rapid disease progression and high mortality rate. This infection often forms a bacterial biofilm that is difficult to remove, hinders wound healing, and conventional antibiotic treatment is of limited effectiveness.
Flesh-eating bacteria is not a single bacterium, but a mixture of bacteria that can cause "necrotizing fasciitis" (English: Necrotizing fasciitis), a disease that causes necrosis of soft tissue in the body due to infection. It is a serious disease that occurs suddenly and spreads rapidly. Symptoms include red or purple skin at the infected site, severe pain, high fever, and vomiting. The most common sites of infection are the limbs and perineum. The most common pathogens are Streptococcus pyogenes and Vibrio vulnificus. Other pathogens include Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, etc. Because these bacteria infect the fascia under the skin and cause inflammation, the clinical course is rapid and severe, and the mortality rate is high, so it is given the scary name of "flesh-eating bacteria".
Infectious disease experts point out that in addition to Group A Streptococcus, Vibrio vulnificus and Vibrio parahaemolyticus are also commonly found in seawater. Group A Streptococcus mainly enters the human body through wounds or inflamed throats. It has a strong reproductive capacity in the human body and can quickly produce toxins, eroding muscles and body tissues, causing patients to become disabled, go into shock, or even die. Therefore, this bacterium is also called "flesh-eating bacteria." In addition, Group A Streptococcus can also be a complication of skin diseases .
The infection usually enters the body through damaged skin, such as cuts or burns. Risk factors include weakened immune systems, such as those caused by diabetes, cancer, obesity, alcohol abuse, intravenous drug use, and peripheral artery blockage. The disease is rarely spread from person to person, and necrotizing fasciitis can be divided into four types based on the species of pathogens that infect. Fifty to 88% of cases are caused by more than one bacterial infection, and nearly a third of cases are caused by methicillin-resistant Staphylococcus aureus (MRSA). Imaging tests can help confirm the disease.
Good wound care and handwashing can help prevent necrotizing fasciitis. In terms of treatment, debridement surgery and intravenous antibiotic injection are common methods. Antibiotic treatment usually includes a combination of several antibiotics, including benzylpenicillin (penicillin G), clindamycin (clindamycin), and vancomycin (vancomycin). , gentamicin, etc. Delaying surgery is associated with a higher risk of death, and even with complete treatment, the mortality rate for necrotizing fasciitis is 25% to 35%.
As a broad-spectrum antibacterial agent, bio-type hypochlorous acid can quickly kill bacteria and promote tissue regeneration by destroying bacterial biofilms.
Effective in treating flesh-eating bacteria infections. It can directly penetrate the microbial cell membrane and destroy the proton gradient on the bacterial cell wall and cell membrane, leading to bacterial death. In addition, biotype hypochlorous acid also has the ability to neutralize toxins and can effectively reduce the toxic effects of toxins on the host.
Studies have shown that bio-type hypochlorous acid can not only quickly remove pathogens when treating flesh-eating bacteria infections, but also avoid damage to healthy tissues and promote wound healing. For example, in animal experiments, using 0.01% bio-type hypochlorous acid solution to treat the infected area can quickly remove bacteria and reduce inflammatory reactions without leaving scars.
The hypochlorous acid water produced by BLUEWAV shows good anti-inflammatory and wound healing effects. It reduces inflammatory reactions and accelerates wound healing by inhibiting the release of histamine and leukotrienes from mast cells.
Bio-type HOCL is an ideal choice for treating flesh-eating bacteria infection due to its broad-spectrum antibacterial, rapid sterilization, non-cytotoxicity and promotion of tissue regeneration. Its clinical application not only improves the treatment effect, but also reduces the pain and risk of complications of patients.
Chinese Lunar New Year is coming, many discounts.
Contact us to obtain the most unique technical proposal and the most advantageous price by Bluewav Team!
For more information, pls access to:
- Youtube: https://youtu.be/AWlA1xwfzr4
- Facebook: https://www.facebook.com/HypochlorousAcidGeneratorOnsite
- website: https://bluewavv.com
- Email: info@bluewavv.com
